Thursday broker round-up
20th Feb 2020 13:40
(Sharecast News) - Travis Perkins: Citigroup upgrades to buy with a target price of 1,900p.
Read moreTuesday broker round up
11th Feb 2020 12:24
(Sharecast News) - Rio Tinto: RBC Capital Markets downgrades to underperform with a target price of 3,300p.
Read moreDeutsche Bank stays at 'hold' on GSK, says shares 'fully valued'
6th Feb 2020 14:15
(Sharecast News) - Analysts at Deutsche Bank stood by their 'hold' recommendation and 1,650.0p target price for shares of GlaxoSmithKline following the drug giant's fourth quarter numbers.
Read moreThursday broker round-up
6th Feb 2020 13:15
(Sharecast News) - CMC Markets: Peel Hunt downgrades to add with a target price of 180p.
Read moreGSK reports lower-than-expected Q4 sales and guides lower
5th Feb 2020 12:46
(Sharecast News) - Drug giant GlaxoSmithKline posted lower-than-expected fourth quarter sales, although profits were in-line with estimates from analysts in the City.
Read moreGSK and Gilead Sciences join race to find coronavirus treatment
3rd Feb 2020 13:27
(Sharecast News) - Top pharmaceutical companies around the world, including GlaxoSmithKline and Gilead Sciences, are increasingly banding together to try and develop vaccines against the new Chinese coronavirus.
Read moreFriday broker round-up
31st Jan 2020 12:55
(Sharecast News) - Hargreaves Lansdown: Liberum upgrades to buy with a target price of 2,125p.
Read moreWednesday broker round-up
22nd Jan 2020 12:52
(Sharecast News) - Experian: Morgan Stanley upgrades to overweight with a target price of 2,950p.
Read moreThursday broker round-up
16th Jan 2020 12:58
(Sharecast News) - Diageo: Jefferies downgrades to hold with a target price of 3,600p
Read moreBarclays downgrades GlaxoSmithKline to 'underweight'
16th Jan 2020 12:57
(Sharecast News) - Barclays downgraded its stance on GlaxoSmithKline shares to 'underweight' from 'equalweight' on Thursday, as it said 2020 looks set to be a much tougher investment year of little growth.
Read moreFDA issues CRL to ViiV Healthcare for cabotegravir and rilpivirine HIV regimen
23rd Dec 2019 07:40
(Sharecast News) - America's health regulator issued a response at the start of the week to GlaxoSmithKline's application for an HIV-1 treatment for virologically suppressed adults from its ViiV Healthcare subsidiary.
Read moreFriday broker round-up
20th Dec 2019 12:28
(Sharecast News) - Segro: HSBC downgrades to hold with a target price of 869p.
Read moreThursday broker round-up
21st Nov 2019 13:05
(Sharecast News) - Fevertree: Deutsche Bank downgrades to hold with a target price of 2,200p.
Read moreFriday broker round-up
15th Nov 2019 13:09
(Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.
Read moreThursday broker round-up
7th Nov 2019 13:28
(Sharecast News) - Associated British Foods: Goldman Sachs upgrades to buy with a target price of 2,750p.
Read more